Page last updated: 2024-10-25

cilostazol and Cerebrovascular Moyamoya Disease

cilostazol has been researched along with Cerebrovascular Moyamoya Disease in 4 studies

Research Excerpts

ExcerptRelevanceReference
"Cilostazol is a selective phosphodiesterase III inhibitor with antiplatelet, antithrombotic, and vasodilatory effects commonly used in peripheral vascular disease."3.01Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions. ( Abedi, A; Choi, W; Nguyen, VN; Rennert, RC; Russin, JJ; Sizdahkhani, S, 2023)
"Adult patients with ischemic moyamoya disease (MMD) who receive treatment with antiplatelet drugs reportedly show improvements in neuropsychological test scores after around 2 years."1.51Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort. ( Ando, S; Chiba, T; Fujiwara, S; Kobayashi, M; Kubo, Y; Miyoshi, K; Ogasawara, K; Sato, S; Setta, K; Tsutsui, S; Yanagihara, W; Yoshida, K, 2019)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Abedi, A1
Sizdahkhani, S1
Choi, W1
Nguyen, VN1
Rennert, RC1
Russin, JJ1
Seo, WK1
Kim, JY1
Choi, EH1
Kim, YS1
Chung, JW1
Saver, JL1
Bang, OY1
Kim, GM1
Chiba, T2
Setta, K2
Shimada, Y1
Yoshida, J1
Fujimoto, K1
Tsutsui, S2
Yoshida, K2
Kobayashi, M2
Kubo, Y2
Fujiwara, S2
Terasaki, K1
Ogasawara, K2
Ando, S1
Miyoshi, K1
Sato, S1
Yanagihara, W1

Reviews

1 review available for cilostazol and Cerebrovascular Moyamoya Disease

ArticleYear
Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions.
    Neurosurgical focus, 2023, Volume: 55, Issue:4

    Topics: Cerebral Revascularization; Cilostazol; Humans; Moyamoya Disease; Platelet Aggregation Inhibitors; S

2023

Other Studies

3 other studies available for cilostazol and Cerebrovascular Moyamoya Disease

ArticleYear
Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study.
    Journal of the American Heart Association, 2021, Volume: 10, Issue:5

    Topics: Adult; Cilostazol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Moyamoya Disease; Platelet

2021
Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:11

    Topics: Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Dr

2018
Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort.
    Neurological research, 2019, Volume: 41, Issue:5

    Topics: Adult; Cilostazol; Clopidogrel; Cognition; Female; Follow-Up Studies; Humans; Male; Middle Aged; Moy

2019